Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bartsch

Showing results (221-230 of 332) with videos related to

Pageof 34
Sort By:
Gut|November 3, 2009
The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancerVolker Fendrich, Nai-Ming Chen, Meike Neef, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|July 27, 2013
Embryonic transcription factors CDX2 and Oct4 are overexpressed in neuroendocrine tumors of the ileum: a pilot studyA E Heverhagen, C Geis, V Fendrich, et al.
Life (Basel, Switzerland)|June 28, 2023
Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer CellsSabine Wächter, Silvia Roth, Norman Gercke, et al.
World Journal of Surgery|October 28, 2017
Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1V Polenta, E P Slater, P H Kann, et al.
Familial Cancer|March 3, 2010
Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer familiesEmily P Slater, Peter Langer, Volker Fendrich, et al.
Journal of Surgical Oncology|October 19, 2011
Targeting the proteasome as a promising therapeutic strategy in thyroid cancerAnnette Wunderlich, Tjadina Arndt, Melina Fischer, et al.
Frontiers in Endocrinology|September 10, 2025
Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinomaSabine Wächter, Detlef K Bartsch, J Riera Knorrenschild, et al.
The Journal of Clinical Endocrinology and Metabolism|September 12, 2014
Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domainDetlef K Bartsch, Emily P Slater, Max Albers, et al.
Journal of Personalized Medicine|February 13, 2021
Cohort Analysis of ADAM8 Expression in the PDAC Tumor StromaChristian Jaworek, Yesim Verel-Yilmaz, Sarah Driesch, et al.
The Journal of Pathology. Clinical Research|August 23, 2024
TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosisSebastian Foersch, Maxime Schmitt, Anne-Sophie Litmeyer, et al.
Pageof 34

Showing results (221-230 of 332) with videos related to

Sort By:
Pageof 34
Gut|November 3, 2009
The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancerVolker Fendrich, Nai-Ming Chen, Meike Neef, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|July 27, 2013
Embryonic transcription factors CDX2 and Oct4 are overexpressed in neuroendocrine tumors of the ileum: a pilot studyA E Heverhagen, C Geis, V Fendrich, et al.
Life (Basel, Switzerland)|June 28, 2023
Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer CellsSabine Wächter, Silvia Roth, Norman Gercke, et al.
World Journal of Surgery|October 28, 2017
Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1V Polenta, E P Slater, P H Kann, et al.
Familial Cancer|March 3, 2010
Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer familiesEmily P Slater, Peter Langer, Volker Fendrich, et al.
Journal of Surgical Oncology|October 19, 2011
Targeting the proteasome as a promising therapeutic strategy in thyroid cancerAnnette Wunderlich, Tjadina Arndt, Melina Fischer, et al.
Frontiers in Endocrinology|September 10, 2025
Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinomaSabine Wächter, Detlef K Bartsch, J Riera Knorrenschild, et al.
The Journal of Clinical Endocrinology and Metabolism|September 12, 2014
Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domainDetlef K Bartsch, Emily P Slater, Max Albers, et al.
Journal of Personalized Medicine|February 13, 2021
Cohort Analysis of ADAM8 Expression in the PDAC Tumor StromaChristian Jaworek, Yesim Verel-Yilmaz, Sarah Driesch, et al.
The Journal of Pathology. Clinical Research|August 23, 2024
TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosisSebastian Foersch, Maxime Schmitt, Anne-Sophie Litmeyer, et al.
Pageof 34